Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited (FSPKF) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
fspkf · stock forecast · 0 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 0 Wall Street analysts in the past 3 months
N/A
0 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$26.00
Consensus
$23.65
+5.0% upside
Low
$21.30
Median: $23.65 · Last Close: $22.52
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$23.65
5.0% upside
High Target
$26
15.5%
Low Target
$21.3
-5.4%
Current Price
$22.52
as of today
Based on analyst price targets, the FSPKF stock price prediction for the next 12 months ranges from $21.3 to $26. The consensus FSPKF price forecast of $23.65 implies 5.0% upside from the current price of $22.52.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $22.33 | ↓ 0.85% |
1-day model range: $22.22–$22.44. Peak: $22.44 (-0.85%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $24 | +6.2% |
| 2028 | $25 | +10.4% |
| 2029 | $26 | +13.3% |
| 2030 | $26 | +15.2% |
| 2031 | — | +16.5% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · FSPKF · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|
Wall Street analysts have recently issued updated ratings on Fisher & Paykel Healthcare Corporation Limited (FSPKF) stock. Of the recent 0 rating actions, 0 were upgrades and 0 were downgrades. 0 analysts currently cover FSPKF.
Analyst Recommendation Trends
FSPKF analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2.3B
↓ 20.4% YoY
Revenue Next Year
$2.6B
↑ 12.7% YoY
EPS This Year
$0.80
EPS Next Year
$0.95
↑ 18.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast FSPKF EPS of $0.80 for the current fiscal year, based on estimates from 1 analysts. The FSPKF revenue forecast is $2.3B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The FSPKF stock forecast is supported by two independent data sources: analyst consensus ratings from 0 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus FSPKF price target is $23.65 (+5.0% upside), with an analyst consensus of N/A.
The FSPKF short-term stock prediction for tomorrow is $22.33 (-0.85%). The FSPKF stock price prediction for 2027 estimates an average of $24. The FSPKF stock prediction for 2030 projects a range of $25–$27.
Fisher & Paykel Healthcare Corporation Limited trades on OTC under the ticker FSPKF. The FSPKF stock outlook for 2027 is broadly mixed, supported by a N/A consensus among 0% of covering analysts.
Frequently asked questions
FSPKF forecast · 8 questionsAccording to 0 Wall Street analysts, the average 12-month FSPKF price target is $23.65, with a high forecast of $26.00 and a low of $21.30. The median price target is shown in the chart above when available. This implies +5.0% potential upside from the current price of $22.52.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.